Arrowhead Pharmaceuticals to present at BofA Securities 2026 Healthcare Conference

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

ARWR

0.00
  • Arrowhead Pharmaceuticals scheduled to participate in multiple investor and medical meetings in May 2026, starting with TIDES USA in Boston on May 11-14.
  • Company set for BofA Securities 2026 Healthcare Conference on May 12-14, including a fireside chat on May 13 at 10:00 am PDT.
  • Additional May appearances include RBC Capital Markets Global Healthcare Conference on May 19-20, followed by EAS Congress on May 24-27, then EASL 2026 on May 27-30.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arrowhead Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260504575415) on May 04, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.